Related Experiment Videos

Ophthalmic toxicity during carboplatin therapy

E M Rankin¹, J F Pitts

¹CRC Dept. of Medical Oncology, Western Infirmary, Glasgow, Scotland.

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|April 1, 1993

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of action.

British journal of cancer·2007

Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.

British journal of cancer·1998

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1996

IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer.

Journal of immunology (Baltimore, Md. : 1950)·1996

See all related articles